marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
IDEXX Laboratories Balance Sheet 2011-2024 | IDXX
Annual Balance Sheet IDEXX Laboratories
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
189 M | 602 M | 651 M | 492 M | 897 M | 876 M | 1.07 B | 1.05 B | 1.04 B | 576 M | -128 M | -221 M | -180 M |
Long Term Debt |
623 M | 694 M | 775 M | 858 M | 699 M | 601 M | 606 M | 593 M | 597 M | 350 M | 150 M | 1.39 M | 2.5 M |
Long Term Debt Current |
19.8 M | 20.4 M | 19.9 M | 17.7 M | 15.3 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
824 M | 902 M | 984 M | 1.08 B | 929 M | 776 M | 763 M | 704 M | 702 M | 446 M | 234 M | 61 M | 54.3 M |
Total Current Liabilities |
952 M | 1.24 B | 764 M | 583 M | 725 M | 770 M | 1 B | 935 M | 857 M | 821 M | 478 M | 406 M | 437 M |
Total Liabilities |
1.78 B | 2.14 B | 1.75 B | 1.66 B | 1.65 B | 1.55 B | 1.77 B | 1.64 B | 1.56 B | 1.27 B | 712 M | 467 M | 491 M |
Deferred Revenue |
37.2 M | 37.9 M | 40 M | 42.6 M | 41.5 M | 41.3 M | 29.2 M | 27.4 M | 25.6 M | 31.8 M | 21.5 M | 20.2 M | 15 M |
Retained Earnings |
4.44 B | 3.6 B | 2.92 B | 2.18 B | 1.6 B | 1.17 B | 804 M | 540 M | 318 M | 1.68 B | 1.49 B | 1.31 B | 1.13 B |
Total Assets |
3.26 B | 2.75 B | 2.44 B | 2.29 B | 1.83 B | 1.54 B | 1.71 B | 1.53 B | 1.47 B | 1.38 B | 1.23 B | 1.1 B | 1.03 B |
Cash and Cash Equivalents |
454 M | 113 M | 144 M | 384 M | 90.3 M | 124 M | 188 M | 155 M | 129 M | 323 M | 279 M | 224 M | 184 M |
Book Value |
1.48 B | 609 M | 690 M | 633 M | 178 M | -9.23 M | -53.8 M | -108 M | -84 M | 118 M | 518 M | 636 M | 540 M |
Total Shareholders Equity |
1.48 B | 609 M | 690 M | 633 M | 177 M | -9.51 M | -54.1 M | -108 M | -84.1 M | 118 M | 518 M | 636 M | 540 M |
All numbers in USD currency
Quarterly Balance Sheet IDEXX Laboratories
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
525 M | 525 M | 621 M | 623 M | 619 M | 697 M | 696 M | 694 M | 761 M | - | 773 M | 775 M | 778 M | 780 M | 779 M | 858 M | 858 M | 858 M | 858 M | 699 M | 699 M | 67.5 M | 67.5 M | 602 M | - | - | - | 607 M | - | - | - | 594 M | - | - | - | 597 M | - | - | - | 350 M | - | - | - | 151 M | - | - | - | 2.5 M | - | - | - | 3.42 M | - | - | - |
Total Non Current Liabilities |
723 M | 718 M | 828 M | 824 M | 819 M | 893 M | 902 M | 902 M | 974 M | - | 982 M | 984 M | 996 M | 1.01 B | 1 B | 1.08 B | 1.08 B | 1.08 B | 1.08 B | 929 M | 929 M | 929 M | 929 M | 776 M | 776 M | 776 M | 776 M | 763 M | 763 M | 763 M | 763 M | 704 M | 704 M | 704 M | 704 M | 702 M | 702 M | 702 M | 702 M | 446 M | 446 M | 446 M | 446 M | 234 M | 234 M | 234 M | 234 M | 61 M | 61 M | 61 M | 61 M | 54.3 M | 54.3 M | 54.3 M | 54.3 M |
Total Liabilities |
1.73 B | 1.83 B | 1.78 B | 1.78 B | 1.79 B | 1.78 B | 1.97 B | 2.14 B | 2.16 B | - | 1.95 B | 1.75 B | 1.63 B | 1.66 B | 1.62 B | 1.66 B | 1.66 B | 1.66 B | 1.66 B | 1.65 B | 1.65 B | 1.65 B | 1.65 B | 1.55 B | 1.55 B | 1.55 B | 1.55 B | 1.77 B | 1.77 B | 1.77 B | 1.77 B | 1.64 B | 1.64 B | 1.64 B | 1.64 B | 1.56 B | 1.56 B | 1.56 B | 1.56 B | 1.27 B | 1.27 B | 1.27 B | 1.27 B | 712 M | 712 M | 712 M | 712 M | 467 M | 467 M | 467 M | 467 M | 491 M | 491 M | 491 M | 491 M |
Deferred Revenue |
38.4 M | 38 M | 38.2 M | 37.2 M | 37.3 M | 37.8 M | 37.8 M | 37.9 M | 40.8 M | - | 40.9 M | 40 M | 41.1 M | 41.1 M | 41.6 M | 42.6 M | 42.6 M | 42.6 M | 42.6 M | 41.5 M | 41.5 M | 41.5 M | 41.5 M | 41.3 M | 41.3 M | 40.9 M | 40.5 M | 29.2 M | 29.2 M | 28.7 M | 29.2 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 25.6 M | 25.6 M | 25.6 M | 25.6 M | 31.8 M | 31.8 M | 31.8 M | 31.8 M | 21.5 M | 21.5 M | 21.5 M | 21.5 M | 20.2 M | 20.2 M | 20.2 M | 20.2 M | 15 M | 15 M | 15 M | 15 M |
Retained Earnings |
5.12 B | 4.88 B | 4.68 B | 4.44 B | 4.25 B | 4.04 B | 3.81 B | 3.6 B | 3.43 B | - | 3.11 B | 2.92 B | 2.76 B | 2.58 B | 2.38 B | 2.18 B | 2.18 B | 2.18 B | 2.18 B | 1.6 B | 1.6 B | 1.6 B | 1.6 B | 1.17 B | 1.17 B | 1.17 B | 1.17 B | 804 M | 804 M | 804 M | 804 M | 540 M | 540 M | 540 M | 540 M | 318 M | 318 M | 318 M | 318 M | 1.68 B | 1.68 B | 1.68 B | 1.68 B | 1.49 B | 1.49 B | 1.49 B | 1.49 B | 1.31 B | 1.31 B | 1.31 B | 1.31 B | 1.13 B | 1.13 B | 1.13 B | 1.13 B |
Total Assets |
3.35 B | 3.41 B | 3.35 B | 3.26 B | 3.09 B | 2.87 B | 2.81 B | 2.75 B | 2.64 B | - | 2.59 B | 2.44 B | 2.39 B | 2.41 B | 2.33 B | 2.29 B | 2.29 B | 2.29 B | 2.29 B | 1.83 B | 1.83 B | 1.83 B | 1.83 B | 1.54 B | 1.54 B | 1.54 B | 1.54 B | 1.71 B | 1.71 B | 1.71 B | 1.71 B | 1.53 B | 1.53 B | 1.53 B | 1.53 B | 1.47 B | 1.47 B | 1.47 B | 1.47 B | 1.38 B | 1.38 B | 1.38 B | 1.38 B | 1.23 B | 1.23 B | 1.23 B | 1.23 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.03 B | 1.03 B | 1.03 B | 1.03 B |
Cash and Cash Equivalents |
309 M | 402 M | 397 M | 454 M | 332 M | 133 M | 111 M | 113 M | 99.2 M | 114 M | 205 M | 144 M | 145 M | 232 M | 351 M | 384 M | 384 M | 384 M | 384 M | 90.3 M | 90.3 M | 90.3 M | 90.3 M | 124 M | 124 M | 124 M | 124 M | 188 M | 188 M | 188 M | 188 M | 155 M | 155 M | 155 M | 155 M | 129 M | 129 M | 129 M | 129 M | 323 M | 323 M | 323 M | 323 M | 279 M | 279 M | 279 M | 279 M | 224 M | 224 M | 224 M | 224 M | 184 M | 184 M | 184 M | 184 M |
Book Value |
1.62 B | 1.58 B | 1.57 B | 1.48 B | 1.3 B | 1.09 B | 841 M | 609 M | 476 M | - | 640 M | 690 M | 755 M | 748 M | 703 M | 633 M | 633 M | 633 M | 633 M | 178 M | 178 M | 178 M | 178 M | -9.23 M | -9.23 M | -9.23 M | -9.23 M | -53.8 M | -53.8 M | -53.8 M | -53.8 M | -108 M | -108 M | -108 M | -108 M | -84 M | -84 M | -84 M | -84 M | 118 M | 118 M | 118 M | 118 M | 518 M | 518 M | 518 M | 518 M | 636 M | 636 M | 636 M | 636 M | 540 M | 540 M | 540 M | 540 M |
Total Shareholders Equity |
1.62 B | 1.58 B | 1.57 B | 1.48 B | 1.3 B | 1.09 B | 841 M | 609 M | 476 M | 457 M | 640 M | 690 M | 755 M | 748 M | 703 M | 632 M | 632 M | 632 M | 632 M | 177 M | 177 M | 177 M | 177 M | -9.51 M | -9.51 M | -9.51 M | -9.51 M | -54.1 M | -54.1 M | -54.1 M | -54.1 M | -108 M | -108 M | -108 M | -108 M | -84.1 M | -84.1 M | -84.1 M | -84.1 M | 118 M | 118 M | 118 M | 118 M | 518 M | 518 M | 518 M | 518 M | 636 M | 636 M | 636 M | 636 M | 540 M | 540 M | 540 M | 540 M |
All numbers in USD currency